- Is Liver and Bile Duct Disease Resear a tax-exempt 501(c)(3)?
- Yes. Liver and Bile Duct Disease Resear is recognised by the IRS as a 501(c)(3) organisation (EIN 20-2112635). The IRS recognised Liver and Bile Duct Disease Resear as tax-exempt in March 2005.
- What is Liver and Bile Duct Disease Resear's EIN?
- Liver and Bile Duct Disease Resear's Employer Identification Number (EIN) is 20-2112635. The EIN was assigned by the IRS in March 2005. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Liver and Bile Duct Disease Resear do?
- To provide education and support for those impacted by primary sclerosing cholangitis (PSC), while searching for treatments and a cure for this rare Liver disease by raising and alligning funding to drive research.
- Where is Liver and Bile Duct Disease Resear located?
- Liver and Bile Duct Disease Resear is located at 6900 E Belleview Ave STE 202, Englewood, CO, 80111.
- When was Liver and Bile Duct Disease Resear founded or recognised by the IRS?
- Liver and Bile Duct Disease Resear was recognised by the IRS as a tax-exempt organisation in March 2005. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Liver and Bile Duct Disease Resear's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Liver and Bile Duct Disease Resear reported $1.9M in total revenue and $3.3M in total expenses.
- Has Liver and Bile Duct Disease Resear been auto-revoked by the IRS?
- No. Liver and Bile Duct Disease Resear (EIN 20-2112635) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Liver and Bile Duct Disease Resear listed in IRS Publication 78?
- Yes. Liver and Bile Duct Disease Resear is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.